Thierry Lambert

Chief Financial Officer

Professional Overview

Thierry Lambert is a seasoned finance executive with extensive experience in the pharmaceutical and biotechnology industries. As the Chief Financial Officer at Sim&Cure, he is responsible for overseeing the company's financial strategy, operations, and risk management initiatives, playing a crucial role in supporting the organization's growth and expansion.

Experience Summary

Current Role

Thierry has been serving as the Chief Financial Officer at Sim&Cure since April 2024. In this position, he is responsible for leading the company's financial planning and analysis, treasury management, and financial reporting functions. He works closely with the executive team to ensure the efficient allocation of resources and the achievement of strategic financial objectives.

Career Progression

Prior to his current role, Thierry held the position of Chief Financial Officer at Theranexus from September 2017 to April 2024. During his tenure, he played a pivotal role in the company's successful expansion and the implementation of robust financial systems and controls. Before that, he served as the Chief Financial Officer at Safe Orthopaedics from July 2015 to September 2017, where he was instrumental in optimizing the company's financial performance and supporting its operational growth.

Thierry's earlier career includes roles as the Group Chief Financial Officer at NATUREX from April 2012 to June 2015, where he oversaw the financial operations of the multinational company. He also held positions as a Corporate Finance Manager at NATUREX from April 2009 to March 2012 and as an Associate Director at CIT from August 2007 to October 2008. Thierry began his career in the finance industry as a Transaction Services Manager at PricewaterhouseCoopers from September 2001 to August 2006.

Academic Background

Thierry holds a Master's degree in Finance from the University of Montpellier, where he specialized in corporate finance and financial analysis.

Areas of Expertise

• Financial planning and strategy

• Financial reporting and analysis

• Treasury management and cash flow optimization

• Risk management and internal control

• Mergers and acquisitions

• Performance optimization and cost management

• Regulatory compliance and financial governance

Professional Impact

Throughout his career, Thierry has demonstrated a strong track record of driving financial excellence and supporting the growth of organizations in the pharmaceutical and biotechnology sectors. His strategic financial leadership and commitment to operational efficiency have contributed to the success of the companies he has worked for.

Conclusion

Thierry Lambert's extensive experience as a Chief Financial Officer, combined with his deep industry knowledge and proven financial management expertise, make him a valuable asset to Sim&Cure. He is poised to continue playing a pivotal role in the company's financial and strategic development, contributing to its long-term success and sustainability.